Baxter Stock Quote: Company Overview and Investor Information

Baxter is a leading global healthcare company that has been in operation for over 75 years. It was founded in 1931 by Dr. Donald Baxter.

Baxter's headquarters are located in Deerfield, Illinois. The company has a diverse portfolio of products and services that cater to various healthcare needs.

Baxter's revenue for 2020 was $10.1 billion. This figure reflects the company's significant presence in the global healthcare market.

Baxter is listed on the New York Stock Exchange (NYSE) under the ticker symbol BAX.

Worth a look: S B I Card Share Price

Baxter International Inc's financial performance has been impacted by a hurricane that hit its intravenous solutions facility, causing a 3.3% drop in shares in premarket trading.

The company cut its annual profit forecast due to the hurricane-related hit, which will likely affect its revenue and net income.

Baxter International Inc's market value is substantial, with a market cap of $17,084,274,000.

Here's a brief summary of Baxter International Inc's past and current market value:

Baxter International Inc's stock performance is a key aspect of its financial performance. The company's stock price has fluctuated between $28 and $43 over the past year, with a current market cap of $17.08 billion.

The company's stock price has also experienced a day range of $32.72 to $33.58. This fluctuation is a common occurrence in the stock market, where prices can change rapidly due to various market and economic factors.

BAX stock has a primary exchange of the New York Stock Exchange (NYSE). This is an important detail for investors, as it provides a clear understanding of where to buy and sell the stock.

Here's a breakdown of Baxter International Inc's stock performance:

The company's stock performance is not just about its price, but also about its revenue and earnings. According to estimates, Baxter International Inc's revenue is expected to reach $11.72 billion in 2026, with an average estimate of 11.712 USD.

The company's earnings per share (EPS) is also expected to increase, with an average estimate of 2.724 USD in 2026. This is a positive trend for the company, as it indicates a potential increase in profitability.

Overall, Baxter International Inc's stock performance is a key aspect of its financial performance. By understanding the company's stock price, revenue, and earnings, investors can make informed decisions about their investments.

The profitability rank of a company is a crucial aspect of its financial performance. A company with a high profitability rank is generally considered to be a good investment opportunity.

One key indicator of profitability is the gross margin percentage, which measures the difference between revenue and cost of goods sold. In this case, the company's gross margin percentage is a respectable 33.42%.

The operating margin percentage is another important metric, as it shows the company's ability to generate profit from its operations. Unfortunately, this company's operating margin percentage is a relatively low 3.21%.

Expand your knowledge: B a E Systems Share Price

Net margin percentage, which takes into account all expenses, is an even more telling indicator. Unfortunately, this company's net margin percentage is a meager 0.63%.

The free cash flow margin percentage (FCF Margin %) is a key metric for investors, as it shows the company's ability to generate cash from its operations. In this case, the company's FCF Margin % is a decent 2.26%.

Return on Equity (ROE) and Return on Assets (ROA) are also important metrics to consider. Unfortunately, this company's ROE % is a relatively low 1.34% and ROA % is even lower at 0.39%.

Here's a summary of the company's profitability metrics:

It's worth noting that the company has been profitable for 9 out of the past 10 years, which is a good sign. However, the 3-Year ROIIC % is a negative -13.45%, which suggests that the company has struggled with profitability in recent years.

Baxter International has a few upcoming events that you should know about. The company will present at the Jefferies London Healthcare Conference on November 20, 2024.

Baxter will also present at the 7th Annual Evercore HealthCONx Conference on December 5, 2024. This is the second time the company has announced this event, but the date remains the same.

Here are some key events from Baxter International's past:

Baxter International has made significant progress in resuming production at its North Carolina facility, which was impacted by hurricane-related flooding.

The company has successfully resumed production on all dialysis solution manufacturing lines at its North Carolina facility.

This is a major breakthrough for Baxter, as it allows them to meet the demand for dialysis solutions and support patients who rely on these products.

Baxter will import 18,000 tons of intravenous products from its international plants to the U.S. by the end of the year.

This move is aimed at mitigating a shortage caused by the production disruptions at its North Carolina facility.

The company is working hard to restore its operations and ensure that patients have access to the products they need.

Baxter aims to restore the number of new patients able to begin using its peritoneal dialysis solutions to pre-Hurricane Helene levels by the end of the year.

A different take: B T Share Price Uk

The 7th Annual Evercore HealthCONx Conference is taking place on Thursday, December 5, 2024. Baxter International Inc. will be presenting at this event.

Baxter International Inc. is a global medtech leader, and this conference is an opportunity for them to share their expertise. Joel Grade will be representing Baxter at the conference.

Baxter International Inc. has a significant presence in the healthcare industry, and this conference will be a great platform for them to showcase their work.

As an investor, it's essential to understand Baxter International Inc's financial performance and market value. The company's diluted earnings per share (EPS) over the trailing twelve months (TTM) is a notable 0.25.

Baxter International Inc's revenue growth year-over-year (YOY) is a respectable 3.8%. This indicates a steady increase in the company's revenue over time.

Here's a quick snapshot of Baxter International Inc's financial performance:

Keep in mind that a profit margin of 0.72 is a relatively low percentage, indicating that the company may be facing some challenges in terms of profitability.

Baxter International Inc's stock performance is a key aspect to consider when evaluating the company's overall health. The company's past financial performance is a good indicator of its future prospects.

Baxter International Inc's revenue has been growing steadily, with a year-over-year (YOY) growth rate of 3.8%.

However, the company's earnings have been experiencing a downturn, with a YOY growth rate of -94.5%.

The company's profit margin is a healthy 0.72%, indicating that it's able to maintain a significant portion of its revenue as profit.

Here's a summary of Baxter International Inc's key financial metrics:

Baxter International Inc. has a diluted earnings per share (EPS) of 0.25, as of the latest available data.

Their revenue growth year-over-year (YOY) is 3.8%, indicating a steady increase in revenue.

However, their earnings growth YOY is -94.5%, showing a significant decline in earnings.

Baxter's profit margin is a notable 0.72%, reflecting their ability to maintain profitability.

The company will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024, providing an opportunity for investors to learn more about their performance.

Here's a summary of Baxter's key performance indicators:

Baxter International Inc. is a global medtech leader that will present at the 7th Annual Evercore HealthCONx Conference.

The conference will take place on Thursday, December 5, 2024, which gives investors a specific date to mark on their calendars.